IGF2BP1 and neoplasm: As a conservative oncogenic driver network, IGF2BP1 promotes SRF expression in a conservative, m6A-dependent manner by inhibiting miRNA-induced SRF mRNA decay, leading to enhanced transcriptional activity of SRF, promoting tumor cell growth and invasion.